Pharmahungary Group is an ISO 9001:2015 certified Hungarian SME developing innovative in-house R&D projects for valorization and providing preclinical and clinical R&D services since 2003.
- Preclinical R&D services: from in vitro to in vivo studies including custom designed, co-morbidity, and large animal models, e.g. Göttingen minipigs, focusing on but not limited to cardiovascular, metabolic, and renal disease models such as infarction, heart failure, arrhythmias, stroke, sepsis, diabetes, insulin resistance, hyperlipidemia, atherosclerosis, obesity, uremia, etc.
- Clinical R&D services: full management of clinical trials with Medical Devices including In Vitro Diagnostics, ATMPs, Investigator Initiated Trials, and niche trials that need strong scientific and regulatory consulting, e.g. clinical trials on sensitive patient population.
- In-house R&D projects: several IP protected drug development projects as well as novel supporting technologies for acute and chronic ischemic injuries, e.g. myocardial infarctions, heart failure, atherosclerosis
Site |
Badges |
|
Pharmahungary Group
7 Záhony utca
Budapest, , 1031
Hungary
|
|
|
Pharmahungary Group
Hajnoczy str. 6.
Szeged, , H-6722
Hungary
|
|
|
Pharmahungary Group
7 Záhony utca
Budapest, , 1031
Hungary
|
|